Company news
Cipher Pharmaceuticals Inc. news in 2014
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2014, newest first.
Cipher Pharmaceuticals Inc. Announces Adoption of Advance Notice By-Law
December 18, 2014
Cipher Pharmaceuticals to present at Piper Jaffray Healthcare Conference 2014
November 25, 2014
Cipher Pharmaceuticals to commence trading on the NASDAQ Global Market
November 20, 2014
Cipher Reports Financial Results for Q3 2014
October 29, 2014
Notice of Cipher Pharmaceuticals Inc. Q3 2014 Conference Call
October 20, 2014
Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment Conference
September 3, 2014
Cipher reports financial results for Q2 2014
July 30, 2014
Cipher Pharmaceuticals and Ranbaxy Announce Distribution Agreement for Isotretinoin Product in Brazil
July 24, 2014
Notice of Cipher Pharmaceuticals Inc. Q2 2014 Conference Call
July 16, 2014
Cipher Pharmaceuticals appoints Shawn Patrick O'Brien as CEO
June 26, 2014
Cipher Pharmaceuticals completes distribution and supply agreement for isotretinoin product in Chile
June 18, 2014
Cipher Pharmaceuticals Inc. to present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
June 5, 2014
Cipher Pharmaceuticals Inc. Reports Voting Results from Annual General Meeting of Shareholders
May 5, 2014
Cipher reports financial results for Q1 2014
May 2, 2014
Notice of Cipher Pharmaceuticals Inc. Q1 2014 conference call and 2013 Annual General Meeting of Shareholders
April 21, 2014
Cipher appoints Thomas Wellner to Board
March 25, 2014
Cipher announces management change
March 14, 2014
Cipher reports record financial results for 2013
February 26, 2014
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2013 conference call
February 12, 2014
Cipher Appoints Gerald McDole as Chair of the Board
February 5, 2014
Cipher achieves sales milestone for Absorica
January 21, 2014